181 related articles for article (PubMed ID: 6205949)
1. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
[TBL] [Abstract][Full Text] [Related]
2. History of patients with chronic granulocytic leukaemia observed in 1974-1984.
Kiss A; Telek B; Oláh E; Pecze K; Iványi J; Rak K
Acta Med Hung; 1986; 43(3):291-300. PubMed ID: 3473428
[TBL] [Abstract][Full Text] [Related]
3. Chronic granulocytic leukaemia. A study of 160 cases.
Kumar L; Sagar TG; Maitreyan V; Majhi U; Shanta V
J Assoc Physicians India; 1990 Dec; 38(12):899-902. PubMed ID: 2096123
[TBL] [Abstract][Full Text] [Related]
4. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
[No Abstract] [Full Text] [Related]
5. Estimation of chronic phase duration in Ph-positive chronic myelocytic leukemia treated with busulfan: statistical analysis on Japanese patients.
Hashimoto T; Ohtaki M; Ueoka H; Munaka M; Kuramoto A; Kamada N
Int J Hematol; 1994 Jul; 60(1):59-69. PubMed ID: 7919239
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in chronic granulocytic leukemia. A study of 798 cases.
Jacquillat C; Chastang C; Tanzer J; Brière J; Weil M; Pereira-Neto M; Gemon-Auclerc MF; Schaison G; Domingo A; Boiron M; Bernard J
Boll Ist Sieroter Milan; 1978 Jul; 57(3):237-46. PubMed ID: 282895
[TBL] [Abstract][Full Text] [Related]
8. [Very long survivals of chronic granulocytic leukemia (author's transl)].
Debray J; Pommier Y; Audebert AA; Krulik M; Smadja N; Zylberait D
Sem Hop; 1980 Feb 18-25; 56(7-8):309-13. PubMed ID: 6246623
[TBL] [Abstract][Full Text] [Related]
9. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome.
Novotny JR; Müller-Beissenhirtz H; Herget-Rosenthal S; Kribben A; Dührsen U
Eur J Haematol; 2005 Jun; 74(6):501-10. PubMed ID: 15876254
[TBL] [Abstract][Full Text] [Related]
10. Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.
Das KV; Thomas M; Pilla MV; Vijayakumar
J Assoc Physicians India; 1977 Aug; 25(8):547-53. PubMed ID: 275251
[No Abstract] [Full Text] [Related]
11. Blastic crisis of chronic myelogenous leukaemia.
Koza I; Cerný V; Bohunický L; Hal'ko J; Ujházy V; Petrek C; Krizan Z
Neoplasma; 1969; 16(4):417-26. PubMed ID: 5259327
[No Abstract] [Full Text] [Related]
12. The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases.
Spiers AS; Bain BJ; Turner JE
Scand J Haematol; 1977 Jan; 18(1):25-38. PubMed ID: 265093
[TBL] [Abstract][Full Text] [Related]
13. Chronic granulocytic leukemia. Review of 536 cases.
Kardinal CG; Bateman JR; Weiner J
Arch Intern Med; 1976 Mar; 136(3):305-13. PubMed ID: 1062970
[TBL] [Abstract][Full Text] [Related]
14. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
Donadieu J; Auclerc MF; Baruchel A; Perel Y; Bordigoni P; Landman-Parker J; Leblanc T; Cornu G; Sommelet D; Leverger G; Schaison G; Hill C;
Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555
[TBL] [Abstract][Full Text] [Related]
15. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of atypical chronic myeloid leukaemia].
Klein UE; Schwarze EW; Schwalbe P; Tolksdorf ME
Dtsch Med Wochenschr; 1976 Jun; 101(24):915-20. PubMed ID: 1064523
[TBL] [Abstract][Full Text] [Related]
17. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
Ionescu V
Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
[No Abstract] [Full Text] [Related]
18. Clinical manifestations of chronic granulocytic leukemia.
Spiers AS
Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
[TBL] [Abstract][Full Text] [Related]
19. [Adrenal function in chronic myeloid leukemia].
Podolak-Dawidziak M; Silber-Kasprzak D
Acta Haematol Pol; 1976 OCT-DEC; 7(4):303-9. PubMed ID: 1069455
[TBL] [Abstract][Full Text] [Related]
20. The relevance of clinical and laboratory data at diagnosis to survival time of chronic granulocytic leukemia patients.
Kotlarek-Haus S; Frydecka I; Koprowska G; Kuliczkowski K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):731-7. PubMed ID: 2436985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]